Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Piramal Healthcare can test Rs 383: Vishal Jajoo

      Piramal Healthcare can test Rs 383, says Vishal Jajoo, Nirmal Bang Sec.

    • Bull's Eye: 12 trading bets for the day

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Piramal Healthcare can add 50%: Baliga

      Piramal Healthcare can add 50% in next three years, says Ambareesh Baliga, COO of Way2Wealth.

    • Sell Piramal Healthcare at Rs 380: Kapadia

      Sell Piramal Healthcare at Rs 380, says Hemen Kapadia, chartpundit.com.

    • Check Out: Super Six stocks for August 5

      On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia, CEO of chartpundit.com, Rakesh Gandhi of LKP Securities and Vishal Kshatriya, Sr Derivative and Technical Analyst, Edelweiss, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Piramal Health looks attractive: Bhamre

      Piramal Health is looking attractive, says Siddharth Bhamre, Angel Broking.

    • Go long in Piramal Health at around Rs 400-405: Bhamre

      Go long in Piramal Healthcare at around Rs 400-405, says Siddharth Bhamre of Angel Broking.

    • Mehta`s view on Piramal Healthcare

      Dipan Mehta, Member BSE/ NSE view on Piramal Healthcare.

    • SP Tulsian view on Piramal Healthcare

      In due course of time Piramal Healthcare will get settled at around Rs 300 per share, says Investment Advisor, SP Tulsian.

    • Piramal Healthcare has target of Rs 465: Thununguntla

      Piramal Healthcare has target of Rs 465, says Jagannadham Thununguntla, Head of Research, SMC Global.

    • Bull's Eye: Stocks to buy today

      Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.

    • Don't see upmove in pharma space: Amit Gupta

      Don't see upmove in pharma space, says Amit Gupta, Chief Manager- Derivatives - ICICI Securities.

    Advisory Alert:

    It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347